Notes
Slide Show
Outline
1
ACoRN

APPALACHIAN CARDIOVASCULAR RESEARCH NETWORK
2
WHAT IS ACoRN?
  • Statewide resource for disease gene identification and genetic data analysis.
  • ACoRN will initially seek to identify genes that cause or contribute to cardiovascular disease.
  • Funded by NIH WV-BRIN grant.
3
ACoRN IS A SCIENTIFIC RESOURCE
4
What are multifactorial diseases?
  • Disease are caused by one or more genes (mutations) and by environmental factors
  • The disease is familial but no Mendelian pattern of inheritance can be detected.
  • Genes that predispose or raise risk are called susceptibility genes
  • Examples: Atherosclerosis, Alzheimer’s, type 2 diabetes, autism, hypertension, obesity
5
Multifactorial diseases
  • Genetic heterogeneity:  more than one susceptibility gene acting alone or in combination
  • Phenotype can vary continuously (quantitative traits)
  • Some have high incidence in a population and called Common Complex diseases
6
West Virginians have high risk of cardiovascular disease
  • WV ranks 49th in the prevalence of heart disease (ReliaStar Financial Corporation)
  • WV ranks 50th in risk of heart disease based on three factors: obesity, hypertension and sedentary lifestyle.  (ReliaStar)
7
ACoRN RESEARCH PLAN
  • IDENTIFY FAMILIES WITH INHERITED CARDIOVASCULAR DISEASES (MONOGENIC AND MULTIFACTORIAL)
  • FIND DISEASE SUSCEPTIBILITY GENES THROUGH GENE MAPPING OR FUNCTIONAL GENOMIC APPROACHES
  • GENE IDENTITY WILL HELP DETERMINE MECHANISM OF PATHOGENESIS
8
ACoRN TEAM
  • CLINICIANS -  IDENTIFY CV AFFECTEDS
  • RURAL CLINICS (5 PLANNED)
  • GENETIC COUNSELORS – PATIENT COUNSELING
  • DATABASE MANAGER- DATA COLLECTION AND SHARING
  • CARDIOVASCULAR RESEARCHERS AND GENETIC ANALYSTS- USE DATA TO IDENTIFY DISEASE GENES AND DEVELOP MODELS OF DISEASE DEVELOPMENT
9
IMPACT ON CARDIOVASCULAR DISEASE
  • IDENTIFICATION OF SUSCEPTIBILITY GENES WILL LEAD TO:
    • EARLY DETECTION OF DISEASE
    • BETTER UNDERSTANDING OF PATHOGENESIS
    • IMPROVED/EARLIER TREATMENT OF CV DISEASE
10
Commercial Interests
  • Identification of disease genes and pathways can lead to development of
    •  (1) new targets for pharmacological agents
    •  (2) methods for reliable detection of mutation genotype
    •  (3) programs which tailor behavior modification to the underlying defect
11
Alzheimer’s Disease
An example of a complex disease
  • Early onset form caused by defects in either APP, presenilin1 or presenilin 2;
  • These account for the majority of early onset cases, but only for 5% of all cases
  • Late onset seems to related to allelic status at APOE where e4 raised risk and decreases age of onset